tirzepatide phase 3 trial SURMOUNT-3 study design This is a 3, multicenter, randomized, SURMOUNT‐4 study design. This is

Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Stud

The authors also acknowledge Mathias Hempfling, MSc, and Anna Zolotor, BSc, from Costello Medical Consulting, Cambridge, UK for statistical support with the analyses

Diabetes carries an increased risk of complications involving the blood vessels

Additionally, research is currently underway investigating the potential role of GLP-1 receptor agonists, like Mounjaro, and their potential antidepressant effects

(2017, Journal of Alzheimers Disease) delivered 8 mg/day of oral LMTM (a methylene blue derivative) to patients with mild-to-moderate Alzheimers for 24 weeks

As you may expect, patches depend on delivering medication through the skin